Gilead Sciences, Inc. (GILD) — Fair Value Analysis

Base-case fair value (P50): $129.41 · Current price: $138.92 · Verdict: Fairly Valued

The Verdict on GILD

Gilead Sciences Inc (GILD) currently trades at $138.92, with our advanced Monte Carlo simulations establishing a median fair value (P50) of $129.41. This rigorous analysis, which runs thousands of forward-looking scenarios, concludes that GILD is Fairly Valued. The -6.8% difference between the current market price and our P50 estimate highlights that the stock is largely trading in line with its intrinsic value, according to our models. This outcome suggests a balanced risk-reward profile, where the market price of $138.92 effectively captures GILD's underlying financial health and future prospects without presenting a significant immediate valuation discrepancy.

How GILD stacks up against peers

In evaluating Gilead Sciences Inc (GILD), our assessment of operational and financial health positions the company in an average quality tier when compared against its sector peers. This average quality is a critical input into our Monte Carlo fair value model, contributing directly to the P50 fair value of $129.41. While GILD's quality tier suggests solid, consistent performance, it does not imply a distinct advantage that would justify a substantial premium over its current trading price of $138.92. The market appears to be accurately reflecting this moderate standing, indicating that the -6.8% gap is a result of a well-informed pricing mechanism rather than misvaluation.

What this means for investors

For investors, the Fairly Valued verdict on Gilead Sciences Inc (GILD), alongside the -6.8% relative to the current price of $138.92, points to a neutral investment posture based solely on the median fair value. The P50 estimate of $129.41 acts as a central tendency for GILD's intrinsic worth, informing market participants that the immediate upside potential is limited from a pure valuation perspective. However, understanding the full range of possibilities is crucial. A free FairCurve account provides access to the complete Monte Carlo distribution, including detailed bear-case and bull-case scenarios, offering a more comprehensive view beyond the P50. Sign up for FairCurve to track GILD's fair value daily and receive instant re-valuations when new earnings or significant fundamental data are released.